Hormonal and genetic risk factors for breast cancer

Surgeon

Volumn 1, Issue 1, 2003, Pages 23-31

  Clamp, A ^a   Danson, S ^a   Clemons, M ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Breast cancer; Genetic; Hormones; Risk factors

Indexed keywords

ESTRADIOL; ESTROGEN;

BONE DENSITY; BONE MINERAL; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; DENSITY; ESTRADIOL BLOOD LEVEL; GENETIC RISK; HUMAN; LIFESPAN; MAMMOGRAPHY; MORBIDITY; MORTALITY; PREDICTION; RETROSPECTIVE STUDY; REVIEW;

EID: 0037650147     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-666X(03)80005-7     Document Type: Review

References (110)

1. Sainsbury, JR, Anderson, TJ, Morgan, DAC. ABC of breast diseases - Breast cancer BMJ 2000; 321: 745-50
2. Clemons, M, Goss, P. Estrogen and the risk of breast cancer. N Engl J Med 2001; 344: 276-85
3. Nandi, S, Guzman, RC, Yang, J. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci USA 1995; 92: 3650-57
4. Liehr, JG. Genotoxic effects of estrogens. Mutat Res 1990; May; 238:269-76
5. Roy, D, Abul-Hajj, YJ. Estrogen-nucleic acid adducts: guanine is major site for interaction between 3,4-estrone quinone and COIII gene. Carcinogenesis 1997; 18: 1247-49
6. Henderson, BE, Ross, RK, Pike, MC et al. Endogenous hormones as a major factor in human cancer. Cancer Research 1982; 42: 3232-39
7. MacMahon, B, Cole, P, Brown, J. Etiology of human breast cancer: a review. J Natl Cancer Inst 1973, 50: 21-42
8. Henderson, BE, Ross, RK, Judd, HL et al. Do regular ovulatory cycles increase breast cancer risk? Cancer 1985; 56: 1206-08
9. Trichopoulos, D, MacMahon, B, Cole, P. Menopause and breast cancer risk. J Natl Cancer Inst 1972; 48: 605-13
10. Rosner, B, Colditz, GA. Nurses' health study: log-incidence mathematical model of breast cancer incidence. J Natl Cancer Inst 1996; 88: 359-64
11. MacMahon, B, Cole, P, Lin, TM et al. Age at first birth and breast cancer risk. Bull World Health Organ 1970; 43: 209-21
12. Key, TJ, Pike, MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988; 24: 29-43
13. Russo, J, Russo, IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 1994; 3: 353-64
14. Colditz, GA. Fat, estrogens, and the time frame for prevention of breast cancer. Epidemiology, 1995; 6: 209-11
15. Thomas, HV, Key, TJ, Allen, DS et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer 1997; 75: 1075-79
16. Berrino, F, Muti, P, Micheli, A et al. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 1996; 88: 291-96
17. Wysowski, DK, Comstock, GW, Helsing, KJ, Lau, HL. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 1987; 125: 791-99
18. Helzlsouer, KJ, Alberg, AJ, Bush, TL et al. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 1994; 18: 79-85
19. Toniolo, PG, Levitz, M, Zeleniuch-Jacquotte, A et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. Journal of the National Cancer Institute 1995; 87: 190-97
20. Thomas, HV, Reeves, GK, Key, TJ. Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes & Control 1997; 8: 922-28
21. Bernstein, L, Yuan, JM, Ross, RK et al. Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies. Cancer Causes Control 1990; 1: 51-58
22. Goldin, BR, Adlercreutz, H, Gorbach, SL et al. The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr 1986; 44: 945-53
23. Key, T.J., Chen, J., Wang, D.Y. et al. Sex hormones in women in rural China and in Britain. Br J of Cancer 1990; 62:631-636.
24. Cauley, JA, Lucas, FL, Kuller, LH et al. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group. Ann Intern Med 1999; 130: 270-77
25. Wolfe, JN. Breast patterns as an index of risk for developing breast cancer. American Journal of Roentgenology 1976; 126: 1130-37
26. Bartow, SA, Pathak, DR, Mettler, FA et al. Breast mammographic pattern: a concatenation of confounding and breast cancer risk factors. Am J Epidemiol 1995; 142: 813-19
27. Greendale, GA, Reboussin, BA, Sie, A et al. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Ann Intern Med 1999; 130: 262-69
28. Brisson, J, Sadowsky, NL, Twaddle, JA et al. The relation of mammographic features of the breast to breast cancer risk factors. Am J Epidemiol 1982; 115: 438-43
29. Saftlas, A.F., Hoover, R.N., Brinton, L.A. et al. Mammographic densities and risk of breast cancer. Cancer 1991; 67: 2833-2838
30. Knight, JA, Martin, LJ, Greenberg, CV et al. Macronutrient intake and change in mammographic density at menopause: results from a randomized trial. Cancer Epidemiology, Biomarkers & Prevention 1999; 8: 123-28
31. Ursin, G, Astrahan, MA, Salane, M et al. The detection of changes in mammographic densities. Cancer Epidemiology, Biomarkers & Prevention 1998; 7: 43-47
32. Ursin, G, Pike, MC, Spicer, DV et al. Can mammographic densities predict effects of tamoxifien on the breast? [letter]. Journal of the National Cancer Institute 1996; 88: 128-29
33. Saftlas, AF, Wolfe, JN, Hoover, RN et al. Mammographic parenchymal patterns as indicators of breast cancer risk. Am J Epidemiol 1989; 129: 518-26
34. Oza, AM, Boyd, NF. Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev 1993; 15: 196-208
35. Boyd, NF, Byng, JW, Jong, RA et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. Journal of the National Cancer Institute 1995; 87: 670-75
36. Olsson, H, Hagglund, G. Reduced cancer morbidity and mortality in a prospective cohort of women with distal forearm fractures. American Journal of Epidemiology 1992; 136: 422-27
37. Persson, I, Adami, HO, McLaughlin, JK et al. Reduced risk of breast and endometrial cancer among women with hip fractures (Sweden). Cancer Causes & Control 1994; 5: 523-28
38. Cauley, JA, Lucas, FL, Kuller, LH et al. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA 1996; 276: 1404-08
39. Zhang, Y, Kiel, DP, Kreger, BE et al. Bone mass and the risk of breast cancer among postmenopausal women. New Engl J Med 1997; 336: 611-17
40. Paffenbarger, RS Jr., Kampert, JB, Chang, HG. Characteristics that predict risk of breast cancer before and after the menopause. Am J Epidemiol 1980; 112: 258-68
41. Pike, MC, Spicer, DV, Dahmoush, L, Press, MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993; 15: 17-35
42. Ziegler, RG, Hoover, RN, Nomura, AM et al. Relative weight, weight change, height, and breast cancer risk in Asian-American women. J Natl Cancer Inst 1996; 88: 650-60
43. Pike, MC, Henderson, BE, Krailo, MD, Duke, A. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet 1983; 2: 926-30
44. Hankinson, SE, Colditz, GA, Manson, JE et al. A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States). Cancer Causes Control 1997; 8: 65-72
45. Newcomb, PA, Longnecker, MP, Storer, BE et al. Recent oral contraceptive use and risk of breast cancer. Cancer Causes Control 1996; 7: 525-32
46. Shapiro, S, Rosenberg, L, Hoffinan, M et al. Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives. Am J Epidemiol 2000, 151: 396-403
47. Ursin, G, Ross, RK, Sullivan-Halley, J et al. Use of oral contraceptives and risk of breast cancer in young women. Breast Cancer Res Treat 1998, 50: 175-84
48. Tryggvadottir, L, Tulinius, H, Gudmundsdottir, GB. Oral contraceptive use at a young age and the risk of breast cancer: an Icelandic, population-based cohort study of the effect of birth year. Br J Cancer 1997; 75: 139-43
49. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives. Lancet 1996; 347: 1713-27
50. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives. Contraception 1996; 54(suppl): 1S-106S
51. Ursin, G, Henderson, BE, Haile, RW et al. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women? Cancer Res 1997; 57: 3678-81
52. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997; 350: 1047-59
53. Persson, I, Weiderpass, E, Bergkvist, L et al. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control 1999; 10: 253-60
54. Magnusson, C, Baron, JA, Correia, N etal. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer 1999; 81: 339-44
55. Schairer, C, Lubin, J, Troisi, R et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000; 83: 485-91
56. Col, NF, Pauker, SG, Goldberg, RJ et al. Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women. Arch Intern Med 1999; 159: 1458-66
57. Grodstein, F, Stampfer, MJ, Colditz, GA et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997; 336: 1769-75
58. Armstrong, K, Eisen, A, Weber, B Assessing the risk of breast cancer. N Engl J Med 2000; 342: 564-71
59. Spicer, DV, Krecker, EA, Pike, MC The endocrine prevention of breast cancer. Cancer Invest 1995; 13: 495-504
60. Inskip, PD. Pelvic radiotherapy, sex hormones, and breast cancer. Cancer Causes Control 1994; 5: 471-78
61. Land, CE. Low-dose radiation - A cause of breast cancer? Cancer 1980; 46: 868-73
62. Land, CE, Boice, JD, Shore, R et al. Breast cancer risk from low-dose exposures to ionizing radiation-Results of parallel analysis of three exposed populations. J Nat Cancer Inst 1980; 65: 353-68
63. Clemons, M, Loijens, L, Goss, P. Breast cancer risk following irradiation for Hodgkin's disease. Cancer Treat Rev 2000; 26: 291-302
64. Tucker, MA, Coleman, CN, Cox, RS et al. Risk of second cancers after treatment for Hodgkin's disease. N Eng J Med 1988; 318: 76-81
65. Sankila, R, Garwicz, S, Olsen, JH et al. Risk of subsequent malignant neoplasms among 1641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five nordic countries. J Clin Oncol 1996; 14: 1422-46
66. Bhatia, S, Robison, LL, Oberlin, O et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Eng J Med 1996; 334: 745-51
67. Gervais-Fagnou, DD, Girouard, C, Laperriere, N et al. Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease. Oncology 1999; 57: 224-31
68. van Leeuwen, FE, Klokman,WJ, Hagenbeek, A et al. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol 1994; 12: 312-25
69. Curtis, RE, Boice, JD. Second cancers after radiotherapy for Hodgkin's disease. N Eng J Med 1988; 319: 244-45
70. O'Brien, PC, Barton, MB, Fisher, R. Breast cancer following treatment for Hodgkin's disease: the need for screening in a young population. Australasian Radiation Oncology Lymphoma Group (AROLG). Australasian Radiol 1995; 39: 271-76
71. Yamanouchi, H, Ishii-Ohba, H, Suzuki, K et al. Relationship between stages of mammary development and sensitivity to gamma-ray irradiation in mammary tumorigenesis in rats. Int J Cancer 1995; 60: 230-34
72. Pharaoh, PD, Day, NE, Duffy, SE et al. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J. Cancer 1997; 71: 800-09
73. Madigan, MP, Ziegler, RG, Benichou, J et al. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Instit 1995; 87: 1681-85
74. Easton, DF, Bishop, DT, Ford, D et al. Genetic linkage analyses in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993; 52: 678-701
75. Gayther, SA, Mangion, J, Russell, P et al. Variation of risk of breast and ovarian cancer associated with different germline mutations of the BRCA-2 gene. Nature Genet 1997; 15: 103-05
76. Miki, Y, Swensen, J, Shattuck-Eisens, D. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA-1. Science 1994; 266: 66-71
77. Wooster, R, Bignell, G, Lancaster, J. et al. Identification of the breast cancer susceptibility gene BRCA-2 Nature 1995; 378: 789-92
78. Marmorstein, LY, Kinev, AV, Chan, GK et al. A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression. Cell 2001; 104: 247-57
79. Pierce, LJ, Strawderman, M, Narod, SA et al. Effect of radiotherapy after breast-conserving therapy in women with breast cancer and germline BRCA-1 BRCA-2 mutations. J Clin Oncol 2000; 18: 3360-69
80. Robson, M, Gilewski, T, Haas, B et al. BRCA- associated breast cancer in young women J Clin Oncol 1998; 16: 1642-49
81. Eerola, H, Vahteristo, P, Sarantaus, L et al. Survival of breast cancer patients in BRCA1, BRCA2 and Non-BRCA 1/2 breast cancer families: a relative survival analysis from Finland Int J Cancer 2001; 93: 368-72
82. Welsch, PL, King, M.-C. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 2001; 10: 705-13
83. Pharoah, P, Mackay, J. Medical genetics and breast cancer: current thinking on the utility of genetic screening in the determination of clinical risk. In 'The Effective Management of Breast Cancer' (2001). Editors: Mansel, R, Smith, I, Kunkler, I, Miles, A. Aesculapius Medical Press
84. Struewing, JP, Hartge, P, Wacholder, S et al. The risk of cancer associated with specific mutations of BRCA-1 and BRCA-2 amongst Ashkenazi Jews. New Engl J Med 1997; 336: 1401-08
85. Thorlacius, S, Struewing, JP, Hartge, JP et al. Population-based study of risk of breast cancer in carriers of BRCA-2 mutations. Lancet 1988; 352: 1337-39
86. Swift, M, Reitnaeur, PJ, Morrell, D et al. Breast and other cancers in families with ataxia telangiectasia. New Engl J Med 1987; 316: 1289-94
87. Fitzgerald, MG, Bean, JM, Hegde, SR et al. Heterozygous ATM mutations do not contribute to early onset breast cancer Nature Genet 1997; 15: 307-10
88. Geoffroy-Perez, B, Janin, N, Ossian, K et al. Cancer risks in heterozygotes for ataxia telangiectasia Int J Cancer 2001; 93: 288-93
89. Trentham-Dietz, A, Newcomb, PA, Storer, BE et al. Body size and risk of breast cancer. Am J Epidemiol 1997; 145: 1011-19
90. Leon, DA, Carpenter, LM, Broeders, MJ et al. Breast cancer in Swedish women before age 50: evidence of a dual effect of completed pregnancy. Cancer Causes Control 1995; 6: 283-91
91. Albrektsen, G, Heuch, I, Kvale, G. Joint effects on cancer risk of age at childbirth, time since birth and attained age: circumventing the problem of collinearity. Stat Med 1999; 18: 1261-77
92. Gail, MH, Brinton, LA, Byar, DP et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81: 1879-86
93. Gail, MH, Benichou, J. Validation studies on a model for breast cancer risk. J Natl Cancer Inst 1994; 86: 573-75
94. Benichou, J, Gail, MH, Mulvihill, JJ. Graphs to estimate an individualized risk of breast cancer. J Clin Oncol 1996; 14: 103-10
95. Bondy, ME, Vogel, VG. Re: Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst 1994; 86: 1350
96. Spiegelman, D, Colditz, GA, Hunter, D, Hertzmark, E. Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst 1994; 86: 600-07
97. Fisher, B, Costantino, JP, Wickerham, DL et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998; 90: 1371-88
98. Claus, EB, Risch, N, Thompson, WD. Autosomal dominant inheritance of early-onset breast cancer Cancer 1994; 73: 643-51
99. Parmigiani, G, Berry, D, Aguilar, O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998; 62: 145-58
100. Womens Concerns Study Group: Raising concerns about family history of breast cancer in primary care consultations: prospective, population-based study. BMJ 2001; 322: 27-28
101. Emery, J, Lucassen, A, Murphy, M et al. Common hereditary cancers and implications for primary care. Lancet 2001; 358: 58-63
102. Peshkin, BN, De Marco, TA, Brogan, BM et al. BRCA 1/2 testing: complex themes in result interpretation J Clin Oncol 2001; 19: 2555-65
103. Hulka, BS Epidemiologic analysis of breast and gynecologic cancers. Prog Clin Biol Res 1997; 396: 17-29
104. Ramon, JM, Escriba, JM, Casas, I et al. Age at first full-term pregnancy, lactation and parity and risk of breast cancer: a case-control study in Spain. Eur J Epidemiol 1996; 12: 449-53
105. Lambe, M, Hsieh, CC, Chan, HW et al. Parity, age at first and last birth, and risk of breast cancer: a population-based study in Sweden. Breast Cancer Res Treat 1996; 38: 305-11
106. Enger, SM, Ross, RK, Paganini-Hill, A, Bernstein, L. Breastfeeding experience and breast cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev 1998; 7: 365-69
107. Garber, JE, Goldstein,AM, Kantor,AF etal. Follow-up study of 24 families with LI-Fraumeni syndrome Cancer Res 1991; 51: 6094-97
108. Lynch, ED, Ostermeyer, EA, Lee, MK et al. Inherited mutations in PTEN that are associated with breast cancer, Cowdens disease and juvenile polyposis. Am J Hum Genet 1997; 61: 1254-60
109. Giardiello, FM, Brensinger, JD, Tersmette, AC et al. Very high risk of cancer in familial Peutz- Jeghers syndrome. Gastroenterology 2000; 119: 1447-53
110. Eccles, DM, Evans, DG, Mackay, J. Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group. J Med Genet 2000; 37: 203-07